Navigation Links
Viagra Also Found To Be Effective For Treatment of Lung Diseases

Pulmonary hypertension is different from hypertension, the common condition of high blood pressure. The pulmonary disease involves extremely high pressure in the artery that carries blood // from the heart to the lungs to pick up oxygen. The disease, also called pulmonary arterial hypertension, can make even routine tasks an ordeal.

Viagra the blue pill that treats erectile dysfunction, a common but less than fatal male malady, may have a new role in treating pulmonary hypertension, a rare but deadly disease that afflicts mainly women.

Results of a clinical trial in India, showed that Viagra increased the ability of patients to exercise by about 40 percent. The authors said that was greater than the effect seen with other drugs in different trials. Although the trial involved only 22 patients, it was the first randomized test to compare Viagra against a placebo for pulmonary hypertension. The drug is even being given to babies, surprising but true .

Some doctors and insurance companies say they have concerns about this use of Viagra, saying it has not been proved effective in rigorous clinical trials, whereas other drugs have. Patients with pulmonary hypertension use the drug every day and in higher doses than men who use it before sex, potentially raising new risks.

Though only about 100,000 people in the United States and Europe have pulmonary hypertension, three drugs have already been approved for the condition and several others are on the way. Researchers say the patient population might grow because doctors, who often miss the condition, are looking more carefully now that treatments are available. Though far from cures for pulmonary hypertension, the new drugs have helped improve the outlook for patients.

Drug manufacturers say they would sell a pulmonary hypertension drug under a different name and in a different form from Viagra to prevent prescription errors. Investigators in the clinical trials said the drug was being provided as a round white pill, not a blue diamond-shaped one, and in doses different from those used for erectile dysfunction.

Given the small patient population, sales of Viagra for pulmonary hypertension are not expected to be that big, the company is pursuing the lung disease treatment because there is an unmet medical need and because the company had been urged to do so by doctors, who had begun testing the drug on their own.

The first drug approved for pulmonary hypertension, in 1995, was Flolan, a version of a natural hormone called prostacyclin, which dilates constricted blood vessels. Flolan, disappears from the body so fast that it must be pumped in 24 hours a day. The catheter used poses a risk of infection, and users must carry a small pump and mix a fresh batch of the drug every day.

Another of the new drugs, Remodulin, is a form of prostacyclin infused under the skin rather than through a catheter. That method lowers the infection risk, but many patients complain of pain. The drug was approved in 2002.

The first oral drug, approved in 2001, was Tracleer from Actelion; it inhibits endothelin, a hormone that helps constrict blood vessels. Though much cheaper than the two other approved drugs, Tracleer can cause liver problems, so users must have their liver enzymes checked every month.

Viagra works by yet another mechanism, inhibiting an enzyme called phosphodiesterase 5. The drug relaxes blood vessels, allowing blood to flow into the penis - or, it is hoped, into the lungs.

However specialists say , approved drugs typically allow someone who cannot climb even one flight of stairs to climb a flight or more, but don't return anybody to what they would perceive as normal health.
'"/>




Related medicine news :

1. Viagra for heart and lung patients
2. The Use Of Viagra for Babies Questioned
3. Viagra Used More By Young Men
4. Treating Altitude Sickness With Viagra
5. Treating Pulmonary Arterial Hypertension In Children With Viagra
6. Women complain Viagra users want too much sex
7. FDA Diminish Hopes On ‘Female Viagra
8. Impotence drug such as Viagra may cause Vision Loss
9. Viagra Halves Effect Of Hormonal Stress On Heart
10. Viagra Drug for improving blood circulation
11. Viagra May Be Useful For Serious Lung Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2016)... ... ... DDi , a Makro company, makes it to ... in eClinical Solutions. DDi has built its solution competency with a unique blend ... DDi provides smarter technology for Clinical Development, Regulatory and Enterprise domains by providing ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Lymphoma ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... South Florida’s philanthropic community at its 10th anniversary Fashion Luncheon on Monday, February ...
(Date:2/12/2016)... ... February 12, 2016 , ... Coco Libre, the maker of ... Carpet Events LA GRAMMY’s Style Lounge Event. Coco Libre will offer musicians and celebrities ... before the big event. The invitation-only gifting suite, held this year at the W ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman and ... J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy Kearns Director, VA ... Southern Nevada Healthcare System. This will be the first Fisher House in Nevada, ...
(Date:2/12/2016)... Pittsburgh, PA (PRWEB) , ... February 12, 2016 ... ... serving families of the Pittsburgh metro area, celebrates the beginning of the latest ... help children develop social skills through art. Donations to this worthy cause are ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... February 12, 2016 ... auf den ungedeckten medizinischen Bedarf bei Lungen- ... seines klinischen Forschungsprogramms bekannt. Das Programm, das ... Verbesserungen ihrer respiratorischen Funktionen und anderer klinischer ... ein Medizintechnikunternehmen, das sich auf den ungedeckten ...
(Date:2/11/2016)... Feb. 11, 2016 PRO-DEX, INC. (NasdaqCM: PDEX) today ... December 31, 2015. The Company also filed its Quarterly Report ... 2016 with the Securities and Exchange Commission today. ... 2015 --> --> Net ... $2.6 million, or 95%, to $5.4 million from $2.8 million ...
(Date:2/11/2016)... 2016   Health 2.0 , the premiere showcase ... announced today " 10 Year Global Retrospective ", a ... the past ten years.   --> ... 2.0 has served as the preeminent thought-leader in the ... of technologies, companies, innovators, and patient-activists through an array ...
Breaking Medicine Technology: